India and the Netherlands are joining forces in the new joint accelation WAH! Accelerator. Several AMR-global partners are involved. On behalf of the NADP, Cornelis Boersma and Simon van der Pol will travel to India. The post AMR platform WAH! Accelerator launched 7 and 8 December appeared first on NADP ..read more

The WHO has released a report on fungal pathogens. It is the first global effort to systematically prioritize fungal pathogens, taking into account their unmet research and development needs, and perceived public health importance. The post WHO publishes fungal priority pathogens list appeared first on NADP ..read more

This 18 November, Antimicrobioal Resistance Multi-Stakeholder Partnership Platform will be launched. The Platform aims to create a global movement for change on AMR, raise awareness of the role everyone should play in tackling AMR, and highlight the importance of a collaborative One Health approach in addressing AMR issues. The post AMR Multi-stakeholder Partnership Platform will be launched soon appeared first on NADP ..read more

AMR-Global organises its 8th Annual Partnership Meeting on November 2. The post Save the date: AMR-Global partnership meeting on November 2 appeared first on NADP ..read more

The GARDP (Global Antibiotic Research & Development Partnerships) has three upcoming webinars. The organization has organized these live seminars to discusscurrent challenges in antibiotic research. The post GARDP present REVIVE: Advancing Antimicrobial R&D appeared first on NADP ..read more

The World Health Organization has released a report on antimicrobial-resistant (AMR) bacterial pathogens. The analysis points to the need of accelerating vaccine development and maximizing current vaccines related to AMR. The post WHO calls for new ways to tackle AMR appeared first on NADP ..read more

Nathaniel Martin has received the Proof of Concept (PoC) grant. The European Research Council (ERC) awarded Martin this grant to continue his research on reducing the toxicity of the antibiotic polymyxin: A potent medicine, but with severe side effects. He receives €150.000. The post Investigation next-generation antibiotics continues with ERC grant Nathaniel Martin appeared first on NADP ..read more

The ERC Advanced grant is awarded to Gilles van Wezel, Professor of Molecular Biotechnology of the Institute Biology Leiden (IBL) of Leiden University. With the 2.5 million euro grant of the European Research Council, he will focus on unravelling the systems that control the production of antibiotics in the bacteria Streptomyces. The post Gilles van Wezel receives ERC Advanced grant to awaken sleeping antibiotics appeared first on NADP ..read more

The AMR Action Fund has announced its first investment to fulfill its aim to bring two to four new antibiotics to market. The fund will provide for research in Adaptive Phagte Therapeutics (APT) and Venatorx Pharmaceuticals. The post First investments of AMR Action Fund appeared first on NADP ..read more

The third AMR Benchmark is an independent report that compares and analyses how pharmaceutical companies are responding to the crisis of antimicrobial resistance. The post 2021 Antimicrobial Resistance Benchmark report appeared first on NADP ..read more